학술논문
Secondary cytoreductive surgery for patients with relapsed epithelial ovarian carcinoma: who benefits?
Document Type
Article
Author
Source
Subject
*OVARIAN cancer
*CANCER relapse
*OVARIAN surgery
*ONCOLOGIC surgery
*DRUG therapy
*DOCETAXEL
*
*
*
*
*
Language
ISSN
1473-3404
Abstract
Presents the results of a study on the feasibility of secondary cytoreductive surgery for patients with relapsed epithelial ovarian cancer. Background on chemotherapy options administered to the patients, including docetaxel; Median progression-free interval from completion of primary therapy; Survival rate for patients with no macroscopic tumor.